UK publishes radiation protection research programme
This article was originally published in Clinica
The UK's Department of Health has published a report detailing the current Radiation Protection Research programme, which reflects a strategy review completed in 2006. The programme covers the priorities for research into the health effects of exposure to ionising radiation and electromagnetic fields, with a view to steering official radiation protection policy. The document sets out the strategy and the priorities raised by the 2006 programme, and provides details of the projects, including duration, costs and the research teams involved. The themes of the 16 projects include: thermal hazard in neonatal ultrasound; long-term sequelae of CT radiation in childhood; and "characterisation of chromosome damage induced in vitro by alpha irradiation and identification of potential markers of in vivo exposure".
You may also be interested in...
The Swiss giant is hoping to get seven more approvals for its blockbuster immunology drug over the next 10 years.
Cadila has filed for approval of saroglitazar for NASH in India. The drug, which could emerge as the first medicine for the indication if approved, is already being used by a million Indian patients for diabetic dyslipidemia and hypertriglyceridemia.
It has been a long and sometimes tortuous development path for Lupuzor but ImmuPharma's chief executive tells Scrip the company's faith in the lupus drug is bearing fruit.